The CCL2-CCR2 axis in primary lung cancer and pulmonary metastasis: from molecular mechanisms to therapeutic potentials.

Huang Y, Ma J, Bi J, Pi G, Li Y, Peng Y, Xiao C, Tuo X, Han G

Open source

DOI
10.3389/fimmu.2026.1871102
Published
2026
Container
Frontiers in immunology
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1871102,
  title = {The CCL2-CCR2 axis in primary lung cancer and pulmonary metastasis: from molecular mechanisms to therapeutic potentials.},
  author = {Huang Y and Ma J and Bi J and Pi G and Li Y and Peng Y and Xiao C and Tuo X and Han G},
  year = {2026},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2026.1871102},
  url = {https://doi.org/10.3389/fimmu.2026.1871102}
}

RIS

TY  - JOUR
TI  - The CCL2-CCR2 axis in primary lung cancer and pulmonary metastasis: from molecular mechanisms to therapeutic potentials.
AU  - Huang Y
AU  - Ma J
AU  - Bi J
AU  - Pi G
AU  - Li Y
AU  - Peng Y
AU  - Xiao C
AU  - Tuo X
AU  - Han G
PY  - 2026
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2026.1871102
UR  - https://doi.org/10.3389/fimmu.2026.1871102
ER  - 

APA

Y, H., J, M., J, B., G, P., Y, L., Y, P., C, X., X, T., & G, H. (2026). The CCL2-CCR2 axis in primary lung cancer and pulmonary metastasis: from molecular mechanisms to therapeutic potentials.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2026.1871102

Source records